Imperial startup NK:IO has raised an additional £1.2m, in a funding round led by Cancer Research Horizons, the innovation arm of Cancer Research UK.NK:IO, a new Imperial startup developing a cell therapy for treating solid tumour cancers, has raised
Imperial spin-out NK:IO, a leader in Natural Killer (NK) cell biology, has announced a collaborative project with the Cell and Gene Therapy Catapult for the advancement of potent cell therapies targeting solid tumours. Click to read more.
NK:IO Secures More Funding for Ovarian Cancer Cell Therapy miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.